US Broker Ratings

UFP Technologies (UFPT) Stock Analysis: Exploring a 21% Upside Potential in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is carving out a niche in the healthcare sector, specifically within the booming medical devices industry. With a market capitalization of..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Offers a 23.62% Potential Upside

Progyny, Inc. (NASDAQ: PGNY), a trailblazer in the healthcare plans industry, is capturing investor attention with its unique approach to fertility and women’s health benefits solutions...

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating a 24% Potential Upside with Strong Buy Ratings

Investors with a keen eye on the healthcare sector might find Guardian Pharmacy Services, Inc (NASDAQ: GRDN) an intriguing prospect. With a market capitalization standing at..

AtriCure, Inc. (ATRC) Investor Outlook: High Forward P/E and Steady Revenue Growth Draw Analyst Attention

For investors eyeing the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents an intriguing opportunity nestled within the medical instruments and supplies industry. With a market capitalization..

Immunovant, Inc. (IMVT) Stock Analysis: Investor Outlook Reveals Promising 76.96% Potential Upside

In the ever-competitive biotechnology sector, Immunovant, Inc. (NASDAQ: IMVT) stands out as a compelling investment opportunity, driven by its innovative approach to treating autoimmune diseases. With..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook Highlights a 28.53% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology industry, is capturing investor attention with its promising financial metrics and a potential upside..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: A Biotech Player with 181.72% Potential Upside

Ascentage Pharma Group International (AAPG), a Chinese biotechnology firm, is capturing attention with its impressive potential upside of 181.72%, according to recent analyst ratings. With a..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Closer Look at the Biotech’s Revenue Surge Amidst Phase 3 Trials

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands at the forefront of pioneering treatments for rare endocrine diseases and related tumors. With a market capitalization of $9.01 billion,..

PGIM Securitized Income ETF (PINC): Stability Amid Uncertainty with Market Cap Insights

In an unpredictable market landscape, the PGIM Securitized Income ETF (NYSE Arca: PINC) emerges as a noteworthy option for investors in search of stability. With a..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Unlocking a 22.69% Potential Upside in Biotechnology

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a standout in the biotechnology sector, has been capturing the attention of investors with its strategic focus on dermatological treatments. Based..

Kymera Therapeutics (KYMR) Stock Analysis: Biotech Innovator with a 28.94% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has emerged as a significant player in the rapidly evolving biotechnology sector, offering a promising outlook for investors keen on innovative..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 59% Potential Upside Amid Robust Revenue Growth

PTC Therapeutics, Inc. (NASDAQ: PTCT), a biopharmaceutical company focused on treating rare disorders, has garnered significant attention due to its impressive revenue growth and potential stock..

Clover Health Investments (CLOV) Stock Analysis: Is a 21% Upside on the Horizon?

Clover Health Investments, Corp (NASDAQ: CLOV) has been making waves in the healthcare sector with its innovative approach to Medicare Advantage plans. As an emerging player,..

CONMED Corporation (CNMD) Stock Analysis: Navigating the Medical Device Sector with Strategic Insights

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector, is making strides in the medical devices industry. Based in Largo, Florida, the company specializes..

Perrigo Company plc (PRGO) Stock Analysis: High Dividend Yield Amidst Challenging Financial Metrics

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, is a significant player in the specialty and generic drug manufacturing industry. Headquartered in Dublin,..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: 277% Potential Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its promising pipeline of drug candidates aimed at addressing..

Tarsus Pharmaceuticals Inc. (TARS) Stock Analysis: Eyeing a 43.6% Potential Upside Amid Robust Revenue Growth

Tarsus Pharmaceuticals, Inc. (TARS), a burgeoning player in the biotechnology sector, has caught the attention of investors with its impressive potential upside and innovative approach to..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech with 192.70% Potential Upside

Investors with an eye on the biotechnology space might want to take a closer look at MoonLake Immunotherapeutics (MLTX), a clinical-stage Swiss company making waves with..

LeMaitre Vascular, Inc. (LMAT): A 30% Upside Potential Ignites Investor Interest

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a stalwart in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its compelling growth potential..

Kiniksa Pharmaceuticals Interna (KNSA) Stock Analysis: Exploring a 23.3% Potential Upside with Robust Revenue Growth

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 23.3%. This biopharmaceutical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds